Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
about
Transitions between epithelial and mesenchymal states during cell fate conversions.Treatment with retinoic acid and lens epithelial cell-conditioned medium in vitro directed the differentiation of pluripotent stem cells towards corneal endothelial cell-like cellsDppa3 expression is critical for generation of fully reprogrammed iPS cells and maintenance of Dlk1-Dio3 imprinting.Therapeutic potential of stem cells in orthopedicsGeneration of induced pluripotent stem cells from human Tenon's capsule fibroblastsCell transplantation for spinal cord injury: a systematic reviewStage-specific differentiation of iPSCs toward retinal ganglion cell lineage.Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation.RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy.Growth factors released from gelatin hydrogel microspheres increase new neurons in the adult mouse brain.Formation of embryoid bodies using dielectrophoresis.In vivo repopulating activity emerges at the onset of hematopoietic specification during embryonic stem cell differentiation.Impact of serum source and inflammatory cytokines on the isolation of endothelial colony-forming cells from peripheral blood.Oligodendrocyte precursor cell transplantation promotes functional recovery following contusive spinal cord injury in rats and is associated with altered microRNA expression.Inner ear progenitor cells can be generated in vitro from human bone marrow mesenchymal stem cells.
P2860
Q34037104-33C3564E-403D-48E5-A878-FB729638DE64Q34795607-D0CDE652-71D7-4D18-933B-5F674A97B0F6Q35161155-41CB2817-92A0-4B0D-9E34-4391C1610916Q35726548-9ECEAA7D-E5A4-4E1A-85C6-BA87ABC93C3BQ36458914-C3544178-212A-472C-BC3F-BF7688A7EEB1Q36635432-39A201C8-BDAD-4F35-89E6-9FD1B20B2A00Q36948793-4389E76D-415B-40B6-985B-F8726330EB36Q37359244-DFC7A917-3878-4D1E-B116-BE0E059877D8Q38786359-A34E70CF-EBA5-413C-BF06-7D70B9C06176Q40580611-884B510E-8A59-4325-995C-48240549D193Q41777840-4F031410-E070-41D3-A2E2-51D745B6CADBQ42115949-72823758-802A-4EA2-9E0D-6B14F7D084AFQ42683851-C9A82F5B-3361-4CB0-BB6A-2EDF551233E2Q44339465-3831E021-7BFF-43A8-87AB-642C1E9022FAQ47233535-5136ACBC-A0B1-463A-B4DF-3E00015700CDQ50358043-8C35C38F-01CA-4959-8E39-9FB39B9E430B
P2860
Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
@en
Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
@nl
type
label
Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
@en
Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
@nl
prefLabel
Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
@en
Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
@nl
P2860
P356
P1476
Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
@en
P2093
Laura Grabel
P2860
P304
P356
10.1002/JCB.23364
P577
2012-02-01T00:00:00Z